10 Heart Attack Clinical Trials in Charlottesville, VA (2026)

Q: How do I join a clinical trial in Charlottesville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you.

Recruiting Heart Attack Studies in Charlottesville

NCT06854458Recruiting

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

This research aims to investigate whether symptoms of chest pain or shortness of breath among the study population are arising due to a heart problem, particularly any reduction of blood flow to the h...

Charlottesville, VANA1,000 participantsBrigham and Women's Hospital

View Study Details

NCT06292117Recruiting

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

The goal of this observational study is to use a genetic test to help doctors prescribe the most effective medications after a patient has a stroke. One type of stroke is caused by a blood clot in bra...

Charlottesville, VA350 participantsUniversity of Virginia

View Study Details

NCT04888104Recruiting

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients...

Charlottesville, VA225 participantsInternational Spine Study Group Foundation

View Study Details

NCT05732103Recruiting

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

The goal of this phase 1/2 multicenter, open-label, single-arm dose escalation and expansion study is to assess the safety, tolerability, pharmacokinetic and pharmacodynamic profile of CTX-712 in pati...

Charlottesville, VAPHASE1225 participantsChordia Therapeutics, Inc.

View Study Details

NCT06533865Recruiting

Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

The goal of this study is to determine whether romosozumab will improve bone density in girls and women with functional hypothalamic amenorrhea (cessation of the menstrual period due to intense exerci...

Charlottesville, VAPHASE3114 participantsMassachusetts General Hospital

View Study Details

NCT03004326Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis....

Charlottesville, VA50 participantsPeter Merkel

View Study Details

NCT05762952Recruiting

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

The goal of this clinical trial is to test the effects of a drug (in the drug class called sodium-glucose cotransporter 2 inhibitors) in women who have symptoms of ischemic heart disease. The main que...

Charlottesville, VAPHASE140 participantsUniversity of Virginia

View Study Details

NCT06382168Recruiting

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

This Phase I/II trial evaluates the safety and preliminary efficacy of DFP-10917 combined with venetoclax in relapsed or refractory acute myeloid leukemia. DFP-10917 is given as a 14-day continuous IV...

Charlottesville, VAPHASE139 participantsDelta-Fly Pharma, Inc.

View Study Details

NCT07182955Recruiting

Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA)

The main goal is to understand what causes reduced fitness in ANOCA and whether targeted exercise can help improve it. This study aims to better understand why patients with Angina and No Obstructive...

Charlottesville, VANA25 participantsUniversity of Virginia

View Study Details

NCT07270978Recruiting

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

The purpose of this study is to understand the safety and estimate the efficacy of combining anti-CD3 x anti-CD33 bispecific antibody (CD33Bi) armed fresh peripheral blood mononuclear cells (CD33Bi FP...

Charlottesville, VAPHASE123 participantsUniversity of Virginia

View Study Details

About Heart Attack Clinical Trials in Charlottesville

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 10 heart attack clinical trials recruiting participants in Charlottesville, VA. These studies are seeking a combined 2,091 participants. Research is being sponsored by Brigham and Women's Hospital, University of Virginia, International Spine Study Group Foundation and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Charlottesville — FAQ

Are there heart attack clinical trials in Charlottesville?

Yes, there are 10 heart attack clinical trials currently recruiting in Charlottesville, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 10 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 19, 2026 from ClinicalTrials.gov